Immediate Impact
5 standout
Citing Papers
Harnessing the AI/ML in Drug and Biological Products Discovery and Development: The Regulatory Perspective
2025 Standout
Navigating the complexities of drug development for inflammatory bowel disease
2024 Standout
Works of Caroline Hurley being referenced
Perceived barriers and facilitators to Risk Based Monitoring in academic-led clinical trials: a mixed methods study
2017
Risk based monitoring (RBM) tools for clinical trials: A systematic review
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Caroline Hurley | 24 | 31 | 28 | 8 | 66 | |
| Carlos Díaz-Montaña | 33 | 35 | 24 | 9 | 80 | |
| Nicola Joffe | 40 | 57 | 44 | 6 | 94 | |
| Mary Rauchenberger | 35 | 51 | 40 | 7 | 169 | |
| Matthew Ventresca | 26 | 40 | 35 | 13 | 171 | |
| Jessica Ritchie | 23 | 54 | 23 | 10 | 167 | |
| Eleanor Dinnett | 19 | 22 | 5 | 5 | 64 | |
| Adel Elfeky | 15 | 30 | 16 | 10 | 70 | |
| Amelia Averitt | 25 | 22 | 6 | 8 | 170 | |
| Jiajun Wen | 16 | 20 | 14 | 7 | 50 | |
| Lourdes Cirugeda | 30 | 77 | 111 | 5 | 194 |
All Works
Login with ORCID to disown or claim papers
Loading papers...